Get the Stockscreener App
33.97
1.91%
-0.66
After Hours:
33.50
-0.47
-1.38%
Vericel Corp stock is traded at $33.97, with a volume of 302.11K.
It is down -1.91% in the last 24 hours and down -7.16% over the past month.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
See More
Previous Close:
$34.63
Open:
$34.69
24h Volume:
302.11K
Relative Volume:
0.56
Market Cap:
$1.72B
Revenue:
$249.12M
Net Income/Loss:
$7.11M
P/E Ratio:
272.63
EPS:
0.1246
Net Cash Flow:
$-8.30M
1W Performance:
-3.99%
1M Performance:
-7.16%
6M Performance:
-7.03%
1Y Performance:
-39.36%
1-Day Range:
$33.58
$35.09
1-Week Range:
$33.58
$36.56
52-Week Range:
$29.24
$58.77
Vericel Corp Stock (VCEL) Company Profile
Name
Vericel Corp
Sector
Industry
Phone
(734) 930-5555
Address
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
33.97 | 1.75B | 249.12M | 7.11M | -8.30M | 0.1246 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-09-24 | Initiated | Canaccord Genuity | Buy |
| Jun-20-24 | Initiated | TD Cowen | Buy |
| Jan-25-24 | Upgrade | Truist | Hold → Buy |
| Aug-08-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-09-22 | Downgrade | Truist | Buy → Hold |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Jan-11-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Initiated | Stephens | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Oct-09-19 | Initiated | H.C. Wainwright | Buy |
| Feb-28-19 | Downgrade | Needham | Buy → Hold |
| Aug-08-18 | Reiterated | Needham | Buy |
| Jul-16-18 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Apr-04-18 | Initiated | Leerink Partners | Outperform |
| Mar-06-18 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-06-18 | Reiterated | Needham | Buy |
| Mar-05-18 | Reiterated | BTIG Research | Buy |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Mar-13-17 | Reiterated | Needham | Buy |
| Dec-22-16 | Initiated | Piper Jaffray | Overweight |
| Nov-09-16 | Reiterated | Needham | Buy |
| Apr-05-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-11-16 | Upgrade | Needham | Hold → Buy |
View All
Vericel Corp Stock (VCEL) Latest News
Vericel Corporation (NASDAQ:VCEL) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
What are the future prospects of Vericel CorporationJuly 2025 News Drivers & Precise Swing Trade Alerts - baoquankhu1.vn
Vericel stock hits 52-week high at $35.84 despite yearly decline By Investing.com - Investing.com South Africa
Vericel stock hits 52-week high at $35.84 despite yearly decline - Investing.com Nigeria
Thrivent Financial for Lutherans Trims Stock Holdings in Vericel Corporation $VCEL - MarketBeat
Vericel (NASDAQ:VCEL) Shares Down 5.5%Should You Sell? - MarketBeat
Vericel Corp (NASDAQ:VCEL) Presents a Strong Growth and Breakout Setup - ChartMill
Vericel: A GARP Investment with Strong Fundamentals and Clear Catalysts - AD HOC NEWS
Vericel Corp (NASDAQ:VCEL) Emerges as a Prime GARP Investment Candidate - Chartmill
Vericel (NASDAQ:VCEL) Upgraded by Wall Street Zen to “Buy” Rating - Defense World
Vericel (NASDAQ:VCEL) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Cartilage Repair-Cartilage Regeneration Market Covering - openPR.com
Is Vericel Corporation stock heavily shorted2025 Volatility Report & AI Enhanced Trading Alerts - bollywoodhelpline.com
Will Vericel Corporation (ATQP) stock boost dividends furtherJuly 2025 Breakouts & Fast Moving Stock Trade Plans - Bollywood Helpline
Vericel Corporation (NASDAQ:VCEL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Vericel Corporation (NASDAQ:VCEL) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Vericel (NASDAQ:VCEL) Stock Rating Lowered by Wall Street Zen - MarketBeat
Debt-Free Balance Sheet, MACI Momentum, And Burn Care Portfolio Put Vericel On Investors' Radar - RTTNews
Why Is Vericel Stock Gaining Tuesday? - Benzinga
Vericel reports preliminary 2025 revenue of $276 million By Investing.com - Investing.com Australia
Vericel reports preliminary 2025 revenue of $276 million - Investing.com
Vericel Corporation Anticipates $276 Million Total Revenue and 23% Growth in Fourth Quarter Results - Quiver Quantitative
Vericel (NASDAQ: VCEL) shares preliminary 2025 results, updates outlook - Stock Titan
Vericel Announces Preliminary 2025 Financial Results and Business Updates - marketscreener.com
Summit Creek Advisors LLC Acquires 138,124 Shares of Vericel Corporation $VCEL - MarketBeat
Vericel Corporation $VCEL Shares Sold by Conestoga Capital Advisors LLC - Defense World
How institutional buying supports Vericel Corporation stockJuly 2025 Review & Risk Managed Investment Entry Signals - Улправда
Bond Watch: Why analysts upgrade Vericel Corporation stockFed Meeting & Free Long-Term Investment Growth Plans - Улправда
Why analysts upgrade Vericel Corporation stockCPI Data & Short-Term Trading Opportunity Alerts - Улправда
Shares soar in Vericel after trial shows ixmyelocel-T reduces cardiac events - The Pharma Letter
Vericel Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 - Quiver Quantitative
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 - Yahoo Finance
Vericel: Growth Plans May Have Run Out Of Gas (Rating Downgrade) - Seeking Alpha
VERICEL CORP (NASDAQ:VCEL) Fits the "Growth at a Reasonable Price" Profile - ChartMill
Vericel (NASDAQ:VCEL) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Vericel (VCEL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Vericel Corporation (NASDAQ:VCEL) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Will Vericel Corporation (ATQP) stock sustain uptrend momentumStock Watchlist Updates & Free Trading Signals to Sharpen Your Edge - bollywoodhelpline.com
How Investors Are Reacting To Vericel (VCEL) Reaffirmed Guidance And MACI-Focused Growth Narrative - simplywall.st
Truist Slashes PT on Vericel Corporation (VCEL) to $45 From $50 - Insider Monkey
Congress Asset Management Co. Lowers Stake in Vericel Corporation $VCEL - MarketBeat
Vericel price target lowered to $45 from $50 at Truist - MSN
VCEL (Vericel) EV-to-OCF : 30.39 (As of Dec. 19, 2025) - GuruFocus
How Vericel Corporation stock reacts to inflationary pressures2025 Valuation Update & Weekly Market Pulse Updates - DonanımHaber
Why Vericel Corporation stock could see breakout soonMarket Volume Report & Long-Term Safe Investment Plans - DonanımHaber
Vericel (VCEL) Sees Target Price Lowered by Truist Securities | - GuruFocus
VCEL FinancialsIncome Statement - Quiver Quantitative
Here's Why We Think Vericel (NASDAQ:VCEL) Might Deserve Your Attention Today - Yahoo Finance
Institutional Investors Accumulate Vericel Shares Amid Positive Earnings Shift - AD HOC NEWS
Vericel Corp (VCEL) CHRO receives 2,625 shares from RSU vesting on 07/22/2025 - Stock Titan
Osterweis Capital Management Inc. Takes $9.71 Million Position in Vericel Corporation $VCEL - MarketBeat
Vericel Corp Stock (VCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):